Skip to main content
. 2023 Feb 19;11(2):626. doi: 10.3390/biomedicines11020626

Figure 7.

Figure 7

Evaluation of the cytotoxicity of CAR-T cells against PC-3M and PC-3M(CD19+) tumor cell lines using xCELLigence biosensor cell analyzer. Dynamic monitoring of proliferation of PC-3M and modified PC-3M(CD19+) cells with and without the addition of T/CAR-T cells. Graphs of cell index versus time are presented as mean, the error bars indicate standard deviation (n = 3). (A)—PC-3M cells; (B)—PC-3M(CD19+) cells.